Targeting paraoxonase-1 in atherosclerosis

By Mackness Mike   Mackness Bharti  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 829-837

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of systemic oxidant/antioxidant status and paraoxonase 1 enzyme activities in psoriatic patients treated by narrow band ultraviolet B phototherapy

By Pektas S.D.   Akoglu G.   Metin A.   Neselioglu S.   Erel O.  

Redox Report, Vol. 18, Iss. 5, 2013-09 ,pp. : 200-204

Maney Publishing

Access to resources Recommend Favorite

Paraoxonase-1 activity in patients with hyperemesis gravidarum

By Verit Fatma Ferda   Erel Ozcan   Celik Hakim  

Redox Report, Vol. 13, Iss. 3, 2008-06 ,pp. : 134-138

Maney Publishing

Access to resources Recommend Favorite

Methylmercury-Induced Inhibition of Paraoxonase-1 (PON1)—Implications for Cardiovascular Risk

By        

Journal of Toxicology and Environmental Health, Vol. 77, Iss. 17, 2014-09 ,pp. : 1004-1023

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme

By  

Current Clinical Pharmacology, Vol. 11, Iss. 4, 2016-12 ,pp. : 259-264

Bentham Science Publishers

Access to resources Recommend Favorite